PR Newswire
London, March 13
Director/PDMR Shareholding
March 13, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
Notification of transactions by persons discharging managerial responsibilities
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Flemming Ornskov | |
| 2. | Reason for the notification | ||
| a) | Position / status | Chief Executive Officer - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | 3,721 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Jeffrey Poulton | |
| 2. | Reason for the notification | ||
| a) | Position / status | Chief Financial Officer - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | 1,160 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Bill Mordan | |
| 2. | Reason for the notification | ||
| a) | Position / status | General Counsel and Company Secretary - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | 859 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Perry Sternberg | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of US Commercial - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of ADSs, acquired as Restricted Stock ("RS") pursuant to the Shire Deferred Bonus Plan 2015, as part of the Executive Annual Incentive. The restrictions applying to the RS will cease on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $177.98 | 100 | ||
| $177.87 | 100 | ||
| $177.99 | 100 | ||
| d) | Aggregated information | Weighted average price | Volume |
| $177.95 | 300 | ||
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | NSDQ | |
| 5. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of ADSs, acquired as Restricted Stock ("RS") pursuant to the Shire Deferred Bonus Plan 2015, as part of the Executive Annual Incentive. The restrictions applying to the RS will cease on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $177.86 | 100 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | BATS | |
| 6. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of ADSs, acquired as Restricted Stock ("RS") pursuant to the Shire Deferred Bonus Plan 2015, as part of the Executive Annual Incentive. The restrictions applying to the RS will cease on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $177.87 | 100 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | NQPX | |
| 7. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of ADSs, acquired as Restricted Stock ("RS") pursuant to the Shire Deferred Bonus Plan 2015, as part of the Executive Annual Incentive. The restrictions applying to the RS will cease on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $177.84 | 30 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | XEDGX | |
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Kim Stratton | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of International Commercial - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each ("Ordinary Shares") | |
| Identification code | ISIN: JE00B2QKY057 | ||
| b) | Nature of the transaction | Receipt of Restricted Stock Units ("RSUs") in respect of notional Ordinary Shares awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | 2,923 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Philip Vickers | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of Research and Development - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | 844 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated them ("PCA") | ||
| a) | Name | Matt Walker | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of Technical Operations - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of Restricted Stock Units ("RSUs") in respect of notional ADSs awarded under the Shire Deferred Bonus Plan 2015 as part of the Executive Annual Incentive. The RSUs will vest on March 10, 2020. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | 414 | ||
| d) | Aggregated information | N/A (single transaction) | |
| e) | Date of the transaction | March 10, 2017 | |
| f) | Place of the transaction | N/A | |
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
| Investor Relations | ||
| Ian Karp | ikarp@shire.com | +1 781 482 9018 |
| Robert Coates | rcoates@shire.com | +44 1256 894874 |
| Media | ||
| Lisa Adler | lisa.adler@shire.com | +1 617 588 8607 |
| Debbi Ford | debbi.ford@shire.com | +1 617 949 9083 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
www.shire.com
